HomeMarkets Markets UBS: Lilly’s Type 2 diabetes and obesity treatment could be ‘one of the best-selling drugs in history’ By news September 22, 2022 0 185 FacebookTwitterPinterestWhatsApp Shares of Eli Lilly & Co. Inc. LLY,+4.89% gained 2.5% in premarket trading on Thursday after UBS upgraded the stock to buy from neutral, saying …This post was originally published on this site Share FacebookTwitterPinterestWhatsApp Subscribe Login Notify of new follow-up comments new replies to my comments Please login to comment 0 Comments Inline Feedbacks View all comments Stay Connected148,824FansLike396,312FollowersFollow2,690SubscribersSubscribe Latest Articles Markets Fed Flip Thursday – Warsh May Hike and Markets Hesitate Markets Warsh Makes His Case With Jargon, and a Penchant for Detail Markets Netanyahu Finally Learns the Truth About Trump Markets The Art of Defeat Markets Will We Hold It Wednesday? S&P 7,500, Dow 52,000, Nasdaq 30,000 and Russell 3,000 Edition Markets 🥷 SpaceX (SPCX) at $2.92T: The Dot-Com Mirror AI The Invisible Hand That’s Already Moving SpaceX’s Stock Price Markets Insulating the President with Loyalists Markets PhilStockWorld June Portfolio Review (Members Only) Markets Can You Make Your Own Luck? Phil Davis and Barry Ritholtz Play Dice with the Universe Market News Trump’s Iran “Deal” Is a Giant Bag of Dogsh💩t Energy The Strait of Hormuz Has Been Closed for 100 Days. Why Aren’t Oil Prices Higher? Energy Trump Winds Down the War He Started With Goals Unmet Markets Manic Monday: SpaceX and Our Companion Picks Head to the Moon Load more